Company Filing History:
Years Active: 1998-1999
Title: Ralph Schure: Innovator in Antiviral Biflavanoids
Introduction
Ralph Schure is a notable inventor based in Darien, IL (US), recognized for his contributions to the field of antiviral agents. With a total of two patents to his name, Schure has made significant strides in the development of pharmaceutical compositions that target viral infections.
Latest Patents
Schure's latest patents focus on biflavanoids and their derivatives as antiviral agents. These patents detail substantially purified antiviral biflavanoids, including robustaflavone, hinokiflavone, amentoflavone, agathisflavone, volkensiflavone, morelloflavone, rhusflavanone, succedaneaflavanone, GB-1a, and GB-2a. The patents also disclose antiviral biflavanoid derivatives and salt forms, such as robustaflavone tetrasulfate potassium salt, along with methods for their preparation. Furthermore, pharmaceutical compositions that incorporate these antiviral biflavanoids, derivatives, or salts are provided. An improved method for obtaining substantially pure robustaflavone from plant material is also described. The biflavanoid compounds can be utilized in treating and preventing viral infections caused by various agents, including influenza, hepatitis, HIV-1, herpes viruses, varicella zoster virus, and measles.
Career Highlights
Ralph Schure is affiliated with Medichem Research, Inc., where he continues to innovate in the field of antiviral research. His work has contributed to the understanding and potential treatment of viral infections, showcasing his commitment to advancing medical science.
Collaborations
Some of Schure's notable coworkers include Yuh-Meei Lin and Michael T Flavin, who have collaborated with him on various projects within the realm of antiviral research.
Conclusion
Ralph Schure's innovative work in the field of antiviral biflavanoids highlights his significant contributions to medical science. His patents reflect a dedication to developing effective treatments for viral infections, underscoring the importance of his research in the pharmaceutical industry.